Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource
Virginia Open Data

Tislelizumab-jsgr

HealthData.Gov

Updated Oct 29, 2026

About this dataset

TEVIMBRA (tislelizumab-jsgr) is an intravenous injection used as an immunotherapy drug that blocks programmed death receptor-1 (PD-1) to help the immune system fight certain cancers. Manufactured by BeOne Medicines USA, Inc., it's available as a 10 mg/mL solution concentrate, approved under BLA761232 and marketed since March 2024. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Tislelizumab-jsgr

    Access the FDA dataset for Tislelizumab-jsgr — ANDA 761232 submitted by Mylan Institutional LLC

    Modified Apr 29, 2026

    Open link: Tislelizumab-jsgr
Prototype by Datopian · not an official government website · data from data.virginia.gov